Efficacy and safety of dronedarone across age and sex subgroups: a post hoc analysis of the ATHENA study among patients with non-permanent atrial fibrillation/flutter.
Anne B CurtisEmily P ZeitlerAysha MalikAndrew BogardNidhi BhattacharyyaJohn StewartStefan H HohnloserPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2021)
These results support the use of dronedarone for the improvement of clinical outcomes among patients aged ≥65 years and regardless of sex.